Solutions · Newsletter writers
A committee behind the byline
A newsletter that only restates a chatbot is a liability. Use isolated seats to collect disagreements you can attribute as simulation — then write in your own name.
- Export splits, not a composite rating.
- Name the method (Lynch, Einhorn) without claiming they emailed you.
- Crypto and ADR boards when the letter covers more than mega-cap US.
Compliance posture
Agents61 is not your lawyer. The product refuses a buy ticket. Your letter still needs your disclaimer. Do not paste a brief as if Buffett signed it.
Questions
Can I republish the briefs?
Treat them as AI-generated research simulation. Attribute the product. Do not impersonate the historical figures.
Related
Research simulation. Isolated briefs never say you should buy. No order routing.